GlaxoSmithKline Pakistan Limited (PSX:GLAXO)
413.42
-2.15 (-0.52%)
At close: Feb 13, 2026
GlaxoSmithKline Pakistan Market Cap
GlaxoSmithKline Pakistan has a market cap or net worth of 131.66 billion as of February 13, 2026. Its market cap has decreased by -0.83% in one year.
Market Cap
131.66B
Enterprise Value
125.02B
Revenue
62.07B
Ranking
n/a
PE Ratio
14.33
Stock Price
413.42
Market Cap Chart
Since September 26, 1994, GlaxoSmithKline Pakistan's market cap has increased from 3.77B to 131.66B, an increase of 3,391.54%. That is a compound annual growth rate of 11.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 131.66B | 6.06% |
| Dec 31, 2025 | 124.13B | -1.80% |
| Dec 31, 2024 | 126.40B | 378.26% |
| Dec 29, 2023 | 26.43B | -5.45% |
| Dec 30, 2022 | 27.95B | -35.70% |
| Dec 31, 2021 | 43.47B | -28.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott Laboratories (Pakistan) | 115.04B |
| The Searle Company | 68.25B |
| AGP Limited | 67.03B |
| Highnoon Laboratories | 54.79B |
| Citi Pharma | 20.88B |
| Ferozsons Laboratories | 18.98B |
| Macter International | 15.72B |
| Otsuka Pakistan | 4.61B |